Arbutus Biopharma Ownership | Who Owns Arbutus Biopharma?
Arbutus Biopharma Ownership Summary
Arbutus Biopharma is owned by 61.61% institutional investors, 21.87% insiders, and 16.52% retail investors. Morgan stanley is the largest institutional shareholder, holding 11.93% of ABUS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Arbutus Biopharma shares.
ABUS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arbutus Biopharma | 61.61% | 21.87% | 16.52% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Morgan stanley | 20.96M | 11.93% | $64.77M |
| Whitefort capital management, lp | 13.34M | 6.97% | $41.23M |
| Blackrock funding, inc. /de | 12.87M | 6.72% | $39.77M |
| Blackrock | 11.55M | 6.58% | $35.70M |
| Two seas capital lp | 10.44M | 5.45% | $32.27M |
| Vanguard group | 8.98M | 4.75% | $29.37M |
| State street | 5.03M | 2.66% | $16.44M |
| Geode capital management | 3.48M | 1.84% | $11.39M |
| Adar1 capital management | 2.83M | 1.48% | $8.73M |
| Adage capital partners gp | 2.58M | 1.34% | $7.96M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Whitefort capital management, lp | 13.34M | 12.10% | $41.23M |
| Corbin capital partners | 682.49K | 3.64% | $2.23M |
| Fourworld capital management | 1.23M | 2.75% | $4.28M |
| Foursixthree capital lp | 2.45M | 2.36% | $8.55M |
| Adar1 capital management | 2.83M | 1.34% | $8.73M |
| Two seas capital lp | 10.44M | 0.54% | $32.27M |
| Blackbarn capital partners lp | 2.34M | 0.42% | $7.66M |
| Quinn opportunity partners | 464.51K | 0.12% | $1.44M |
| Entrypoint capital | 61.10K | 0.09% | $188.81K |
| Saba capital management | 1.26M | 0.09% | $3.89M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 20.96M | 0.01% | 12.13M |
| Foursixthree capital lp | 2.45M | 2.36% | 2.45M |
| Blackrock | 11.55M | 0.00% | 1.15M |
| Adage capital partners gp | 2.58M | 0.01% | 1.00M |
| Two seas capital lp | 10.44M | 0.54% | 977.36K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Stempoint capital lp | - | - | -467.88K |
| Hudson bay capital management lp | 965.00K | 0.01% | -280.90K |
| Corbin capital partners | 682.49K | 3.64% | -170.82K |
| Lmr partners llp | - | - | -158.25K |
| Susquehanna fundamental investments | - | - | -115.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Foursixthree capital lp | 2.45M | 2.36% | 2.45M | $8.55M |
| Schroder investment management group | 121.31K | 0.00% | 121.31K | $374.86K |
| Franklin resources | 92.16K | 0.00% | 92.16K | $301.36K |
| Assenagon asset management | 39.61K | 0.00% | 39.61K | $122.39K |
| Prelude capital management | 25.32K | 0.01% | 25.32K | $78.23K |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -3.00 |
| Nelson, van denburg & campbell wealth management group | -24.00 |
| Central trust | -100.00 |
| Opal wealth advisors | -100.00 |
| Gamma investing | -127.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 173 | -6.49% | 118,008,158 | 5.57% | 61 | 1.79% | 79 | 6.76% | 43 | -18.87% |
| Mar 31, 2025 | 9 | -94.48% | 30,187,875 | -70.98% | 16 | 0.54% | 8 | -89.19% | - | -100.00% |
| Dec 31, 2024 | 161 | 5.23% | 103,747,487 | 2.96% | 54 | 1.93% | 73 | -5.19% | 44 | 41.94% |
| Sep 30, 2024 | 153 | 12.50% | 100,767,700 | 4.58% | 53 | 2.03% | 77 | 8.45% | 31 | 3.33% |
| Jun 30, 2024 | 135 | 5.47% | 96,359,003 | 16.04% | 54 | 2.19% | 71 | 26.79% | 30 | -6.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 4.92M | 2.57% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.77M | 2.49% | -105.70K |
| Morgan Stanley Insight A | 4.24M | 2.23% | 399.58K |
| Morgan Stanley Insight I | 4.10M | 2.14% | -97.92K |
| Morgan Stanley Insight | 4.10M | 2.14% | -97.92K |
| iShares Russell 2000 ETF | 3.55M | 1.85% | -67.52K |
| MS INVF Global Insight Z | 2.50M | 1.31% | - |
| Morgan Stanley Inst Inception I | 2.10M | 1.10% | -23.88K |
| Morgan Stanley Inception | 2.10M | 1.10% | -23.88K |
| EQ/Morgan Stanley Small Cap Growth K | 1.67M | 0.87% | 1.88K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 04, 2025 | HASTINGS DAVID C | Chief Financial Officer | Sell | $72.83K |
| Feb 04, 2025 | Sims Karen | Chief Medical Officer | Sell | $63.52K |
| Feb 04, 2025 | McElhaugh Michael J. | Interim President & CEO | Sell | $78.10K |
| Feb 04, 2025 | Naftzger J. Christopher | General Counsel and CCO | Sell | $37.21K |
| Aug 14, 2024 | MANCHESTER KEITH S | - | Sell | $32.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q1 | - | 4 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 4 |
ABUS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools